No internet connection — showing the saved version of the page.

Abeona Therapeuti…

USUSD
← to the screener
US:ABEOLSE:0H7R

Abeona Therapeutics Inc (LSE:0H7R) — Biotechnology: Pharmaceutical Preparations. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
abeonatherapeutics.com
Investor relations
investors.abeonatherapeutics.com/
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Headquarters
CLEVELAND, United States
Management
Vishwas Seshadri
Employees
226
Listed since
29.01.2018 (LSE:0H7R)
Shares outstanding
57.18 M as of 2026-08-10
Year: +11.5% · 3 years: +53.4% · 5 years: +221.0% (excluding splits)
DateSharesChange
10.08.202657.18 M+0.3%issuance (dilution)
08.05.202657 M−0.09%no significant change
11.03.202657.05 M+5.3%issuance (dilution)
07.11.202554.19 M+5.7%issuance (dilution)
08.08.202551.28 M+0.2%issuance (dilution)
09.05.202551.16 M+5.4%issuance (dilution)
11.03.202548.53 M+11.6%issuance (dilution)
12.11.202443.47 M+0.4%issuance (dilution)
02.08.202443.31 M+5.2%issuance (dilution)
10.05.202441.19 Msplit 1.5:1
06.03.202427.36 M+10.4%issuance (dilution)
01.11.202324.77 M+0.07%no significant change
01.08.202324.76 M+31.8%issuance (dilution)
04.05.202318.78 M+6.0%issuance (dilution)
21.03.202317.71 M+3.1%issuance (dilution)
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Free float
36.85 M
Market cap
282.49 M USD
Insiders
10.96%
Institutions
74.9%
Industry (SIC)
Pharmaceutical Preparations
P/E
loss
P/B
1.97
FCF
−81.5 M USD
Debt
15.0 M USD
net cash
Earnings and FCF — for the 12 months to 30.06.2026 (the company's latest report).
NAV
2.24 USD · P/NAV 2.29
Balance sheet date30.06.2026
Assets180 M USD
− Liabilities51.4 M USD
= NAV (equity of the company's shareholders)128 M USD
= Tangible NAV128 M USD
Shares57 225 919
NAV per share2.24 USD
Tangible NAV per share2.24 USD
Share price (0H7R)5.1200 USD
P/NAV2.29
NAV history
Balance sheet dateNAVNAV per share
30.06.2026128 M USD2.24 USD
31.03.2026145 M USD2.55 USD
31.12.2025159 M USD2.89 USD
30.09.2025171 M USD3.27 USD
30.06.2025164 M USD3.19 USD
31.03.202541.4 M USD0.85 USD
31.12.202444.0 M USD0.96 USD
30.09.202445.8 M USD1.05 USD
Description

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksABEO primaryUSD4.4 -1.57%common stock
LSE London Stock Exchange0H7R IOBUSD5.12 +0.00%common stock

Price for 3 months

3M1Y3Y5Y
up day down dayHover / tap a day — open, close, high and low prices

Top holders

HolderStakeSharesReport date
Nantahala Capital Manage…8.98%5.14 M2026-06-30
Blackrock Inc.5.86%3.35 M2026-06-30
Cable Car Capital, LP5.26%3.01 M2026-06-30
AIGH Capital Management…5.22%2.99 M2026-06-30
Vanguard Capital Managem…3.87%2.21 M2026-06-30
OneDigital Investment Ad…2.89%1.65 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.67%1.53 M2026-06-30
AWM Investment Company,…2.6%1.49 M2026-06-30
SESHADRI VISHWAS (Chief…≈2.25%1.29 M2026-09-29
Geode Capital Management…2.21%1.26 M2026-06-30
Kennedy Capital Manageme…2.17%1.24 M2026-06-30
Goldman Sachs Group Inc2.14%1.22 M2026-06-30
iShares Trust-iShares Ru…2.04%1.17 M2026-08-31
VANGUARD INDEX FUNDS-Van…1.1%627 7692026-06-30
VAZZANO JOSEPH WALTER (C…≈0.84%482 8882026-09-29
Fidelity Salem Street Tr…0.84%478 7702026-07-31
O'MALLEY BRENDAN M (Offi…≈0.74%421 2262026-09-29
iShares Trust-iShares Ru…0.71%405 1922026-08-31
Simplify Exchange Traded…0.6%345 4162026-06-30
VASANTHAVADA MADHAV (Off…≈0.5%285 7212026-09-29
Fidelity Concord Street…0.48%273 5632026-07-31
VANGUARD SCOTTSDALE FUND…0.41%235 6322026-05-31
AMOROSO MICHAEL (Directo…≈0.38%217 7792026-01-26
CHARLES FAITH L. (Direct…≈0.31%176 4072026-01-26
WUCHTERL DONALD A (Direc…≈0.29%167 9352026-02-02
ALLAND LEILA (Director)≈0.28%162 6142026-06-30
iShares Trust-iShares Mi…0.26%148 6882026-08-31
iShares Trust-iShares Co…0.21%119 5422026-08-31
SILVERSTEIN CHRISTINE BE…≈0.21%119 5622026-06-15
ZEIHER BERNHARDT G (Dire…≈0.15%84 4582026-01-26